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High mammographic density is a well-known risk factor for breast cancer. This study aimed to search for a possible birth cohort
effect on mammographic density, which might contribute to explain the increasing breast cancer incidence. We separately
analyzed left and right breast density of Dutch women from a 13-year period (2003–2016) in the breast cancer screening
programme. First, we analyzed age-specific changes in average percent dense volume (PDV) across birth cohorts. A linear
regression analysis (PDV vs. year of birth) indicated a small but statistically significant increase in women of: 1) age 50 and born
from 1952 to 1966 (left, slope = 0.04, p = 0.003; right, slope = 0.09, p < 0.0001); 2) age 55 and born from 1948 to 1961 (right,
slope = 0.04, p = 0.01); and 3) age 70 and born from 1933 to 1946 (right, slope = 0.05, p = 0.002). A decrease of total breast
volume seemed to explain the increase in PDV. Second, we compared proportion of women with dense breast in women born in
1946–1953 and 1959–1966, and observed a statistical significant increase of proportion of highly dense breast in later born
women, in the 51 to 55 age-groups for the left breast (around a 20% increase in each age-group), and in the 50 to 56 age-groups
for the right breast (increase ranging from 27% to 48%). The study indicated a slight increase in mammography density across
birth cohorts, most pronounced for women in their early 50s, and more marked for the right than for the left breast.
Background
With about one fourth of all cancer cases in women, breast can-
cer is the most common type of cancer and the leading cause of
cancer death among women worldwide.1 Many risk factors for
breast cancer are known, including family history, age at menar-
che, age at menopause, and alcohol use (see Ref. 2 and references
therein). Among these, one of the strongest risk factors is mam-
mographic density (see Refs. 3,4 and references therein), i.e. a
measure of the proportion of fibroglandular tissue among the
total of fibroglandular and fat tissue in the breast.
Age is another key factor influencing the incidence of breast
cancer, although not in a linear way.5 Indeed, only about 7% of
breast cancer cases occur before the age of 40 years,6 and
the incidence pattern of breast cancer follows a rather char-
acteristic curve, with increasing incidence over age but with
a less steep slope after menopause, producing the so-called
Clemmesen’s hook.5
In a recent pooled analysis,7 the effect of aging and meno-
pausal status on mammographic density was investigated, and
the authors found density to decrease with increasing age, and
to be lower in postmenopausal than in premenopausal women
of the same age. A Danish study with repeated measurements
for the same women over a 10-year period8 indicated a birth
cohort effect on density with an increase in the proportion of
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women with mixed/dense mammographic density from women
born in the 1920s to women born in the 1940s.
In our study, we analyzed mammographic data obtained
during the Dutch breast cancer screening programme to inves-
tigate the possible presence of a birth cohort effect on mammo-
graphic density.
Materials and Methods
Data description and study population
We analyzed 3D volumetric breast measurements of the total
breast volume and of the fibroglandular volume for the left and
right breasts separately, automatically estimated from 2D digital
mammograms (mostly mediolateral oblique (MLO) and few cra-
niocaudal (CC) views) using the VolparaDensity software (ver-
sion 1.5.0, Volpara Solutions, Wellington, New Zealand).9
Data were collected during a population-based breast cancer
screening programme, in particular from the Preventicon screen-
ing unit in Utrecht, the Netherlands, of the Foundation of Popu-
lation Screening Mid-West, where women aged 50–75 years were
invited to screening every second year. Overall, our data covered
a time span of 13 years, from September 2003 to September
2016. Digital mammograms were obtained using Lorad Selenia
DM systems (Hologic, Danbury, Conn.).
In total, data derived from 69,041 Dutch women. Of these,
16,562 were screened once, 11,512 screened twice, 12,041 three
times, 12,412 four times, 10,081 five times, 5,704 six times,
727 seven times, 2 eight times. Each screening/observation cor-
responded to both left and right breast measurement. Overall,
215,091 observations were included in our analysis. Of these,
1,004 measurements of the left breast and 1,366 of the right
breast were missing. The presence of implants was the most
frequent cause for missing values.
The observations included information on women aged
48–76 years at screening and born in the period 1929–1966. Years
of birth were included only partially in the original dataset.
Therefore, when missing, they were calculated as min{year of
screening – age at screening}, where the minimum was taken
over all the observations of the same woman. The heat map in
Figure 1 provides an overview of the year of birth/age distribution.
Statistical analysis
First, we studied the time trend of the percent dense volume
(PDV = (fibroglandular volume)/(breast volume)), separately
for left and right breast, across consecutive birth cohorts for
given age groups, namely women 50, 55, 60 and 70 years old.
For the four age-groups, a linear regression model of the PDV
against year of birth has been applied. Outcome measures are the
slope of the regression line, the standard error, and the p-value
for t-test, determining whether the slope differs significantly from
zero. Similar analyses were made for the total breast volume and
for fibroglandular tissue volume.
Second, we classified each single dense tissue measurements
according to the Volpara Density Grade (VDG) 4th Edition
(see e.g. Ref. 10), defined as follows:
VDG = 1 for 0% ≤ PDV < 4.5%,
VDG = 2 for 4.5% ≤ PDV < 7.5%,
VDG = 3 for 7.5% ≤ PDV < 15.5%,
VDG = 4 for PDV ≥ 15.5%.
The VDG categories are based on the BI-RADS density scale,
and several previous studies have found a moderate or good
agreement between them, see Refs. 11,12 and references therein.
As dense breast is a risk factor for breast cancer, one could
hypothesize that the increasing trend in the breast cancer inci-
dence rate13 might be partially explained by an underlying
increase of mammographic density. Therefore, we compared
the proportions of women with VDG = 3 and VDG = 4, strati-
fied by age, within two groups, namely women born in the
years 1946–1953 and 1959–1966. The two periods corresponded
to the 2nd and 4th quartile of the year of birth distribution
(counted only once per woman), and were chosen in order to
ensure overlap in age-groups and to use data of latest avail-
able birth cohorts (see Fig. 1). Relative risk (RR) with 95%
confidence interval, obtained with unconditional maximum
likelihood method, with small-sample adjustment, and corre-
sponding chi-squared test p-values were calculated. Relative
risk adjusted for small sample is defined as follows. Denoting
by 0,1 the 1946–1953 and 1959–1966 groups, respectively,
we have RR= c1=n1c0 + 1ð Þ= n0 + 1ð Þ, where ci, denotes the number of
cases in the group i (e.g. c1 = number of women with VDG = 4
in 1959–1966 group) and ni the total number of women in
the group i (e.g. n0 = number of women in 1946–1953 group).
In our dataset, 63 women had been screened twice at the
same age. For these women, we selected the observation with
highest VDG, or the earliest observation when the VDG was
the same, separately for left and right breast. Therefore, in this
analysis each woman was correctly counted only once per age
group. Missing values were excluded from the counting.
Statistical analyses were performed with R 3.5.0, using the
Epitools package. All plots were created in R 3.5.0, with ggplot2,
grid, gridExtra and gtable packages.
What’s new?
Women with dense breast tissue are at increased risk of breast cancer. Here, changes in mammographic density were investigated
across birth cohorts in women enrolled in a breast cancer screening program in the Netherlands. The findings reveal an increase in
the average fraction of dense tissue in the breast across cohorts. In particular, greater breast density was observed in a higher
proportion of women in later-born than earlier-born birth cohorts. The increase was most significant among women in their early
50s and may be linked to a reported shift toward older age at menopause among women in Europe.
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Results
Trend in the proportion of dense tissue
Our data showed a strong age component in proportion of dense
volume with an average percentage of dense volume being
around 10% for women aged 50 years, and around 6% for
women aged 70 years (Fig. 2.) The data did, however, also indi-
cate an increase of the proportion of dense volume in later born
as opposed to earlier born. Indeed, a linear regression model
showed a statistically significant increase in different age groups,
with quite remarkable differences between left and right breast
(see Table 1 and Fig. 2). Namely, for the left breast we observed
a statistically significant positive slope (Sl = 0.04, p = 0.003) in
the 50 age group, whereas we found nonsignificant values in the
other age-groups. Rather surprisingly, the increase of the propor-
tion of the dense tissue emerged more clearly in the right breast.
Indeed, the 50 and 70 age groups showed statistically significant
positive regression slopes (Sl = 0.09 and p < 0.0001, Sl = 0.05
and p = 0.002, respectively), as well as the 55 age group, although
with a p-value close to the significance threshold (Sl = 0.04 and
p = 0.01). Furthermore, it was worth noticing that, in all age
groups, the linear regression slope for the right breast was larger
than the corresponding value for the left breast.
In order to better understand the possible cause of the
observed trend in the PDV, we separately analyzed the trends
of the total breast volume and in dense tissue volume (Table 1
and Fig. 2). Rather surprisingly, we found a sharp and statisti-
cally significant decline of the total breast volume in women aged
55 (Sl = −6.58, p < 0.0001 for the left breast, and Sl = −7.98,
p < 0.0001 for the right breast) and 60 (Sl = −9.31, p < 0.0001
for the left breast, and Sl = −9.66, p < 0.0001 for the right
breast). A smaller reduction was seen in the other age groups,
although nonstatistically significant.
A similar pattern was observed for the dense tissue volume,
however, with some important differences. Indeed, while for
the 55 and 60 age groups the dense tissue volume mirrored the
decline seen in the total breast volume (thus, resulting in the
stable proportion between the dense and the fat tissue reflected
in the PDV). In the 50 age group the dense tissue volume
remained stable in the left breast (Sl = −0.07, p = 0.47) and
increased slightly in the right breast (Sl = 0.21, p = 0.03) (thus,
resulting in the slightly increasing PDV for the left breast and
the more sharply increasing PDV for the right breast).
Once again, one could observe a different behavior between
left and right breast, with the latter showing a more pronounced
decline of the total breast volume and a less rapid decrease
(or even an increase) of the dense tissue volume. This fact could
therefore explain the observed differences in the increase of the
percent dense volume between the left and the right breasts.
Figure 1. Heatmap of the number of observations (N) by age and year of birth. [Color figure can be viewed at wileyonlinelibrary.com]
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Proportion of women with high VDG
As a second analysis, we compared the proportion of women
with the highest proportions of dense breast among those
born in 1946–1953 and 1959–1966, stratifying by age. Results,
namely proportion of women with VDG = 3 and VDG = 4,
respectively, in each group, corresponding relative risk adjusted
Figure 2. Mean (dots) of the percent dense volume, breast and dense tissue volume by age group and birth cohort, and regression lines with
95% confidence regions (shaded areas). [Color figure can be viewed at wileyonlinelibrary.com]
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for small-sample, confidence interval and p-value, are shown in
Tables 2 and 3 and Figure 3. The age interval, 49–57 years, con-
sidered in our analysis corresponded to the subset of observations
where data from both groups of birth cohorts were available.
The analysis showed that the proportion of women with
VDG = 3 was nonstatistically significant different between the
two groups (see Table 2). On the other hand, the proportion of
women with highly dense breast (i.e., VDG = 4) was generally
Table 2. Proportion of women with VDG = 3, stratified by age, relative risk (1959–1966 vs. 1946–1953), 95% confidence interval and p-value
Women born in 1946–1953 Women born in 1959–1966
Left breast Right breast Left breast Right breast Left breast Right breast
Age VDG = 3 / tot
(%)
VDG = 3 / tot
(%)
VDG = 3 / tot
(%)
VDG = 3 / tot
(%)
RR1 (95% CI)
p-value
RR1 (95% CI)
p-value
49 5 / 14
(35.7)
5 / 13
(38.5)
2,254 / 6,087 (37.0) 2,319 / 6,098 (38.0) 0.93
(0.46–1.87)
p = 0.9
0.89
(0.45–1.77)
p = 0.97
50 175 / 469
(37.3)
179 / 472
(37.9)
3,171 / 8,729 (36.3) 3,225 / 8,732 (36.9) 0.97
(0.86–1.09)
p = 0.7
0.97
(0.86–1.09)
p = 0.7
51 249 / 716
(34.8)
255 / 717
(35.6)
2,245 / 6,324 (35.5) 2,296 / 6,334 (36.2) 1.02
(0.92–1.13)
p = 0.7
1.02
(0.92–1.13)
p = 0.7
52 358 / 1,042
(34.4)
379 / 1,046 (36.2) 2,198 / 6,311 (34.8) 2,248 / 6,313 (35.6) 1.01
(0.92–1.11)
p = 0.8
0.98
(0.90–1.07)
p = 0.7
53 676 / 1907
(35.4)
696 /1908 (36.5) 1,333 /4064 (32.8) 1,420 / 4,081 (34.8) 0.92
(0.86–1.00)
p = 0.04
0.95
(0.89–1.02)
p = 0.2
54 723 / 2,124
(34.0)
755 /2129 (35.5) 1,215 / 3,760 (32.3) 1,311 / 3,785 (34.6) 0.95
(0.88–1.02)
p = 0.2
0.98
(0.91–1.05)
p = 0.5
55 1,029 / 3,254
(31.6)
1,058 / 3,253
(32.5)
591 / 1989 (29.7) 658 / 2006 (32.8) 0.94
(0.86–1.02)
p = 0.1
1.01
(0.93–1.09)
p = 0.8
56 1,029 / 3,313
(31.1)
1,095 / 3,317
(33.0)
434 / 1,399
(31.0)
454 / 1,403 (32.4) 1.00
(0.91–1.10)
p = 0.97
0.98
(0.90–1.07)
p = 0.7
57 1,508 / 4,914
(30.7)
1,541 / 4,917
(31.3)
36 / 110
(32.7)
35 / 109
(32.1)
1.07
(0.81–1.40)
p = 0.6
1.02
(0.78–1.35)
p = 0.9
1Small-sample adjusted.
Table 1. Slope (Sl), corresponding standard error (SE) and p-value of the regression lines in the four age-groups
Age group 50 years 55 years 60 years 70 years
Birth cohorts
1952–1966 1948–1961 1943–1956 1933–1946
Left b. Right b. Left b. Right b. Left b. Right b. Left b. Right b.
Percent dense volume
Sl 0.04 0.09 −0.01 0.04 −0.02 0.03 0.02 0.05
SE 0.01 0.02 0.02 0.02 0.01 0.02 0.02 0.02
p-value 0.003 <0.0001 0.71 0.01 0.09 0.07 0.31 0.002
Breast volume
Sl −1.28 −2.5 −6.58 −7.98 −9.31 −9.66 −0.39 −3.05
SE 1.26 1.27 1.66 1.65 1.73 1.73 2.08 2.05
p-value 0.31 0.05 <0.0001 <0.0001 <0.0001 <0.0001 0.85 0.13
Fibroglandular tissue volume
Sl −0.07 0.21 −0.76 −0.52 −1.18 −0.82 −0.30 −0.12
SE 0.09 0.10 0.10 0.11 0.10 0.10 0.11 0.11
p-value 0.47 0.03 <0.0001 <0.0001 <0.0001 <0.0001 0.007 0.30
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higher for the later born women (group 1959–1966) compared
to those born earlier (group 1946–1953), but again with some
differences between left and right breasts (see Table 3). More
specifically, for the left breast at the age of 53 years we observed
a statistically significant 26% increase in the proportion of
women with VDG = 4 for women born in 1959–1966 as com-
pared to those born in 1946–1953. A similar increase appeared
at ages 51, 52, 54 and 55, with similar values which were still
statistically significant, but with p-values close to the signifi-
cance threshold (p = 0.02, 0.02, 0.02, 0.01, respectively). For the
right breast, we obtained a statistically significantly increased
risk from the older to the younger birth cohort for all ages from
50 to 56, ranging from 27% up to 48%.
Discussion
Our study of mammographic data from the Dutch breast can-
cer screening programme indicated the presence of a possible
birth cohort effect on mammographic density, in particular
for women in their 50s, and more marked for the right than
for the left breast.
Our time trend analysis indicated that a reduction of the
average breast volume occurred across birth cohorts, and
that changes in the dense tissue part did not follow the same
behavior. Therefore, the observed increase of the PDV could
be attributed both to the combination of a more rapid
decline of the fat tissue volume than of the dense tissue vol-
ume (e.g. 50 age group, left breast), and to the combination
of a decrease of the fat tissue volume with an increase of the
dense tissue volume (e.g. 50 age group, right breast). More-
over, the asymmetric behavior between the two breasts could
be seen also in the secular trends, where the decline in total
breast volume seems to be most pronounced in the right breast,
while the decline in the dense tissue volume looks more rapid
in the left one.
In the analyzed dataset, we did not have individual data on
breast cancer risk factors. Possible explanations of the observed
patterns therefore have to be inferred for available population
data. Users of hormone therapy have a higher mammographic
density than nonusers.14–18 The possible birth cohort effect on
mammographic density observed in the earlier Danish study
was seen for both users and nonusers of hormone therapy,
but the density levels were considerably higher in the user
than in the nonuser group.8 The Dutch data analyzed in our
study were derived from September 2003 to September 2016.
Table 3. Proportion of women with VDG = 4, stratified by age, relative risk (1959–1966 vs. 1946–1953), 95% confidence interval and p-value
Women born in 1946–1953 Women born in 1959–1966
Left breast Right breast Left breast Right breast Left breast Right breast
Age VDG = 4 / tot
(%)
VDG = 4 / tot
(%)
VDG = 4 / tot
(%)
VDG = 4 / tot
(%)
RR1 (95% CI)
p-value
RR1 (95% CI)
p-value
49 2 / 14
(14.3)
1 / 13
(7.7)
1,188 / 6,087 (19.5) 1,368 / 6,098 (22.4) 0.98
(0.27–3.52)
p = 0.6
1.57
(0.24–10.33)
p = 0.2
50 77 / 469
(16.4)
69 / 472
(14.6)
1,524 / 8,729 (17.5) 1,773 / 8,732 (20.3) 1.05
(0.85–1.30)
p = 0.6
1.37
(1.10–1.71)
p = 0.003
51 89 / 716
(12.4)
93 / 717
(13.0)
989 / 6,324 (15.6) 1,208 / 6,334 (19.1) 1.25
(1.02–1.53)
p = 0.02
1.46
(1.20–1.77)
p < 0.001
52 119 / 1,042
(11.4)
135 / 1,046 (13.0) 882 / 6,311 (14.0) 1,058 / 6,313 (16.8) 1.21
(1.01–1.45)
p = 0.02
1.29
(1.09–1.52)
p = 0.002
53 186 / 1907
(9.8)
197 /1908 (10.3) 502 /4064 (12.3) 625 / 4,081 (15.3) 1.26
(1.07–1.48)
p = 0.003
1.48
(1.27–1.72)
p < 0.001
54 190 / 2,124
(9.0)
213 /2129 (10.0) 411 / 3,760 (10.9) 484 / 3,785 (12.8) 1.22
(1.03–1.43)
p = 0.02
1.27
(1.09–1.48)
p = 0.001
55 269 / 3,254
(8.3)
317 / 3,253
(9.7)
204 / 1989 (10.3) 258 / 2006 (12.9) 1.24
(1.04–1.47)
p = 0.01
1.32
(1.13–1.54)
p < 0.001
56 248 / 3,313
(7.5)
283 / 3,317
(8.5)
128 / 1,399
(9.2)
163 / 1,403 (11.6) 1.22
(0.99–1.49)
p = 0.05
1.36
(1.13–1.63)
p = 0.001
57 305 / 4,914
(6.2)
377 / 4,917
(7.7)
11 / 110
(10.0)
10 / 109
(9.2)
1.61
(0.91–2.84)
p = 0.1
1.19
(0.66–2.17)
p = 0.6
1Small-sample adjusted.
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In the Netherlands, as in other high-income countries, the use
of hormone therapy decreased,19 following the publication of two
landmark studies on the adverse effects of hormone therapy.20,21
However, even before 2003 the use of hormone therapy was
already infrequent in the Netherlands,19 and by far the majority of
the 50-year old Dutch women included in our study have lived
through menopause and early menopausal age after the decline in
use of hormone therapy. Hormone therapy is therefore unlikely to
explain the increasing trend over birth cohorts in mammographic
density for 50 years old women indicated in our data. Other possi-
ble causes of the observed trends could be changes in reproductive
factors such as parity and younger age at first birth, known to be
associated with lower mammographic density.22–24
The pooled analysis of cross-sectional mammographic density
data from women from different countries and ethnic groups
showed mammographic density (defined as dense area/breast
area, these being read from 2D images) to be lower in postmeno-
pausal than in premenopausal women of the same age.7 Firm
data on changes in menopausal age across birth cohorts are
sparse. A number of studies do, however, indicate a shift toward
older age of natural menopause in European women.25–30 Such a
shift could explain our finding of an increase in the average
PDV among women in their 50s, but it is more difficult to
see how this could relate to our finding of a decrease in the
fatty volume. However, assuming that BMI correlates posi-
tively with breast volume, our finding of an increasing den-
sity related to an overall decrease of breast volume would
Figure 3. Upper plots: proportion of women with VDG = 4 (PDV ≥ 15.5%), by age group, in the birth cohorts 1946-1953 vs. 1959-1966. Lower
plots: corresponding relative risk and 95% confidence interval. Note that, for the sake of readability, the upper endpoints of the confidence
intervals for the 49 and 57 age groups are not included in the plots (cf. Table 3). [Color figure can be viewed at wileyonlinelibrary.com]
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confirm the inverse association between density and BMI
found in previous studies.23,24
Nonetheless, despite the lack of data on breast cancer inci-
dence or hormonal therapy in our study population, our finding
could contribute to explain, at least partially, the birth cohort
effect on the increasing breast cancer incidence observed in the
Netherlands31 across the 1938–1962 birth cohorts, as well as in
the UK,32 Spain33 and France.34
In our data, changes in mammographic density were
more pronounced in the right breast than in the left breast.
Although differences between left and right breasts are
known and documented in literature (e.g. laterality of breast
cancer35,36), to the best of our knowledge this is the first
study indicating that the change in mammographic density
is proceeding asymmetrically for the two breasts. Further
studies are needed to investigate, and possibly confirm, such
phenomenon.
On a parallel note, the results of our analysis on mammo-
graphic density seem to be in accordance with the well-known
decrease of breast density with age, and they further suggest
that this might be due to an absolute reduction of dense tissue
volume (see Fig. 2). However, further statistical analyses are
needed to confirm this.
Our study had both strengths and limitations. First, it
was a strength that the data derived from a 13 year observa-
tion period from a population-based screening programme.
Second, all data consist of objective, fully automated mea-
surements, rather than determined by radiologists. Third,
no change in the mammography technology took place dur-
ing the data collection period and always the same version
of the Volpara software was used for the extraction of the
volume measurements.
Furthermore, our study differs from previously mentioned
studies on mammographic density trends in two ways. First,
our data included a longer observation period. Second, our
data included more recent birth cohorts of women (born up
to the 1960s).
The study had, however, also some limitations. Even though
all data came from one screening unit, a change in the team of
radiographers may have influenced mammography positioning
and/or compression techniques. Another limitation was the lack
of individual information on risk factors, such as childhood body
mass index, height, parity and age at first birth, which are known
to influence mammographic density.37
Finally, it is worth pointing out that the results of the time
trend analyses of the breast measurements have to be inter-
preted carefully. Indeed, we did not in advance expect to find
(and, as a matter of fact, we did not observe) a linear relation
between those quantities and women’s year of birth. There-
fore, the linear regression used in the analysis is only meant
to capture a general time trend behavior, which should be bet-
ter analyzed with longer time series.
In conclusion, this study based on mammographic density
measurements collected over a 13 year period in the Nether-
lands indicated that density increased over birth cohort in par-
ticular for women in their 50s. This could possibly be related to
an increasing age of natural menopause, but further longitudi-
nal studies are needed to test this observation.
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